Resultados: 10

    Guía de práctica clínica para el uso de uterotónicos en la prevención de la hemorragia posparto: versión larga

    La presente guía fue desarrollada siguiendo los lineamientos del Manual para la elaboración de guías de la Organización Mundial de la Salud, de forma general se creó un grupo para la elaboración con enfoque multidisciplinario compuesto por expertos sobre el tema, epidemiólogos, metodólogos y paci...

    Guía de práctica clínica para el uso de uterotónicos en la prevención de la hemorragia posparto: versión resumida

    La presente guía se elaboró siguiendo los lineamientos del Manual para la elaboración de guías de la Organización Mundial de la Salud. De forma general, se creó un grupo desarrollador multidisciplinario, compuesto por expertos temáticos, epidemiólogos, metodólogos y pacientes. Con base en la evi...

    Guía de práctica clínica para el uso de uterotónicos en la prevención de la hemorragia posparto

    Objetivo: Proveer recomendaciones para mejorar la calidad del cuidado y desenlaces para mujeres que reciben atención del parto, en relación a la prevención de la hemorragia posparto (HPP) por atonía uterina en El Salvador. Métodos: La presente guía fue desarrollada siguiendo los lineamientos del Ma...

    WHO recommendation on umbilical vein injection of oxytocin for the treatment of retained placenta

    Postpartum haemorrhage (PPH) is commonly defined as a blood loss of 500 mL or more within 24 hours after birth and affects about 5% of all women giving birth around the world. Globally, nearly one quarter of all maternal deaths are associated with PPH and, in most low-income countries, it is the main cau...

    WHO recommendation on advance misoprostol distribution to pregnant women for prevention of postpartum haemorrhage

    Postpartum haemorrhage (PPH) is commonly defined as a blood loss of 500 mL or more within 24 hours after birth and affects about 5% of all women giving birth around the world. Globally, nearly one quarter of all maternal deaths are associated with PPH and, in most low-income countries, it is the main cau...

    WHO recommendation on routes of oxytocin administration for the prevention of postpartum haemorrhage after vaginal birth

    Postpartum haemorrhage (PPH) is commonly defined as a blood loss of 500 mL or more within 24 hours after birth and affects about 5% of all women giving birth around the world. Globally, nearly one quarter of all maternal deaths are associated with PPH and, in most low-income countries, it is the main cau...

    WHO recommendations: uterotonics for the prevention of postpartum haemorrhage

    Postpartum haemorrhage (PPH) is commonly defined as a blood loss of 500 ml or more within 24 hours after birth, and affects about 5% of all women giving birth around the world. The primary aim of these recommendations is to improve the quality of care and outcomes for women giving birth, as they relate t...

    WHO recommendation on tranexamic acid for the treatment of postpartum haemorrhage

    The primary audience includes health professionals who are responsible for developing national and local health protocols (particularly those related to PPH) and those directly providing care to pregnant women and their newborns, including midwives, nurses, general medical practitioners, obstetricians, m...

    Guideline: delayed umbilical cord clamping for improved maternal and infant health and nutrition outcomes

    Member States have requested guidance from WHO on the effects of late cord clamping for improving maternal and infant nutrition and health, as a public health strategy in support of their efforts to achieve the Millennium Development Goals, as well as the global targets set in the Comprehensive implement...

    WHO recommendations for the prevention and treatment of postpartum haemorrhage

    Postpartum haemorrhage (PPH) is a major cause of mortality, morbidity and long term disability related to pregnancy and childbirth. Effective interventions to prevent and treat PPH exist and can largely reduce the burden of this life-threatening condition. Given the availability of new scientific evidenc...